Tracey L. Evans

First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring Somatic<i>EGFR</i>Mutations

Lecia V. Sequist, Renato Martins, David R. Spigel et al. · Journal of Clinical Oncology · 2008 · 834 citations · Full text

Medicine, Oncology, Pharmacology +17

Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer

Stephen Bagley, Shawn Kothari, Charu Aggarwal et al. · Lung Cancer · 2017 · 529 citations

Medicine, Immunology, Oncology +16

Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non–Small Cell Lung Cancer

Charu Aggarwal, Jeffrey C. Thompson, Taylor A. Black et al. · JAMA Oncology · 2018 · 490 citations · Full text

Medicine, Genetics, Oncology +17

<i>EGFR</i> -Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes

Nicolas Marcoux, Scott Gettinger, Grainne M. O’Kane et al. · Journal of Clinical Oncology · 2018 · 471 citations

Medicine, Oncology, Pathology +17

Combined MTOR and autophagy inhibition

Reshma Rangwala, Yunyoung C Chang, Janice Hu et al. · Autophagy · 2014 · 419 citations · Full text

Medicine, Oncology, Pharmacology +17